|
|
|
Insider
Information: |
Van Elsas Andrea |
Relationship: |
Chief Scientific Officer |
City: |
Oss |
State: |
P7 |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
438,367 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$17,705,643 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
438,367 |
|
|
Total
Value |
$17,705,643 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Chinook Therapeutics Inc |
KDNY |
Chief Scientific Officer |
2020-02-25 |
438,367 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
20 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
|
2020-02-25 |
4 |
S |
$3.51 |
$23,954 |
D/D |
(6,823) |
438,367 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
|
2020-01-03 |
4 |
S |
$1.19 |
$87,108 |
D/D |
(73,311) |
445,190 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
|
2019-12-12 |
4 |
S |
$1.16 |
$2,550 |
D/D |
(2,192) |
518,501 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
|
2019-09-13 |
4 |
S |
$1.31 |
$24,279 |
D/D |
(18,593) |
520,693 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
|
2019-06-26 |
4 |
A |
$0.00 |
$0 |
D/D |
275,000 |
539,286 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
|
2019-03-19 |
4 |
AS |
$3.96 |
$24,107 |
D/D |
(6,081) |
239,557 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
|
2019-02-26 |
4 |
S |
$4.25 |
$29,120 |
D/D |
(6,844) |
245,638 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
|
2018-12-28 |
4 |
AS |
$2.57 |
$4,901 |
D/D |
(1,907) |
252,482 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
|
2018-12-12 |
4 |
S |
$2.93 |
$6,365 |
D/D |
(2,171) |
254,389 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
|
2018-09-24 |
4 |
AS |
$5.83 |
$45,022 |
D/D |
(7,726) |
256,560 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
|
2018-09-13 |
4 |
S |
$6.50 |
$63,394 |
D/D |
(9,754) |
264,286 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
|
2018-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
67,825 |
274,040 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
|
2018-07-17 |
4 |
AS |
$6.96 |
$72,803 |
D/D |
(10,454) |
206,215 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
|
2018-02-26 |
4 |
S |
$6.48 |
$44,522 |
D/D |
(6,874) |
216,669 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
|
2017-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
20,962 |
223,543 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
|
2017-09-13 |
4/A |
S |
$10.99 |
$54,072 |
D/D |
(4,922) |
202,581 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
|
2017-09-13 |
4 |
S |
$10.99 |
$54,072 |
D/D |
(4,922) |
207,231 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
|
2017-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
32,625 |
212,153 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
|
2017-09-12 |
4/A |
A |
$0.00 |
$0 |
D/D |
27,975 |
207,503 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Chief Scientific OfficerOffice |
|
2017-08-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
179,528 |
|
- |
|
20 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|